# US 2024/0245846 A1 · Syringe

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0245846 A1
- Document ID: US20240245846A1
- Status: Published application
- Kind: A1
- Application number: 18/587,715
- Filed: 2024-02-26
- Published: 2024-07-25
- Earliest claimed: 2019-08-06
- Assignees: MicroVention, Inc.
- Applicants: MicroVention, Inc.
- Inventors: Samuel Chen; Steve Trom
- Web page: https://patentgrep.com/patent/US20240245846A1

## CPC

- A61M 5/007: {for contrast media}
- A61K 49/0404: {containing barium sulfate}
- A61M 5/31: Details
- A61M 5/002: {Packages specially adapted therefor, e.g. packages for syringes or needles or kits for diabetics}
- A61M 5/31596: {comprising means for injection of two or more media, e.g. by mixing}
- A61M 2005/3104: {Caps for syringes without needle}
- A61M 2005/3106: {Plugs for syringes without needle}
- A61M 2005/312: {comprising sealing means, e.g. severable caps, to be removed prior to injection by, e.g. tearing or twisting}
- A61M 2202/0468: non-physiological
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Described herein are syringe caps including a plug portion and a protruding member extending from one end of the plug portion. The protruding member can extend a length greater than a depth of an accumulated component in the syringe.

## Claims

### Claim at position 1

1-17. (canceled)

### Claim 18

A method of degassing a composition in a syringe having accumulated material over a delivery end of a syringe, the method comprising:
removing gas from a composition within the syringe after removing a syringe cap including a protruding member that extends longitudinally into the syringe and through the accumulated material thereby forming a tunnel through the accumulated material.

### Claim 19 (depends on 18)

The method of claim 18, wherein the accumulated material is a visualization agent.

### Claim 20 (depends on 18)

The method of claim 18, wherein the syringe cap further includes a plug portion having a first end and a second end, wherein the plug portion is configured to attach to the delivery end of the syringe.

### Claim 21 (depends on 18)

The method of claim 18, wherein the protruding member extends about 2 mm to about 20 mm.

### Claim 22 (depends on 18)

The method of claim 18, wherein after removing gas from the composition, the syringe cap is reengaged, and the composition is reconstituted.

### Claim 23 (depends on 22)

The method of claim 22, wherein upon reconstitution of the composition, the syringe is attached to a delivery catheter and prepared for injection.

### Claim 24

A method of preparing a liquid embolic composition for administration to a patient, the method comprising:
removing gas from the liquid embolic composition, including a first component and a second component, in a pre-filled syringe after removing a syringe cap including a protruding member that extends a length greater than a depth of the second component when accumulated;
re-engaging the syringe cap after removing the gas from the liquid embolic composition;
reconstituting the liquid embolic composition; and
attaching the pre-filled syringe to a delivery catheter for administration to the patient.

### Claim 25 (depends on 24)

The method of claim 24, wherein the first component is a carrier, a therapeutic, or a combination thereof.

### Claim 26 (depends on 24)

The method of claim 24, wherein the second component is a visualization agent.

### Claim 27 (depends on 24)

The method of claim 24, wherein the protruding member has a cross-sectional shape.

### Claim 28 (depends on 24)

The method of claim 24, wherein the protruding member is configured to create a tunnel through the second component when accumulated.

### Claim 29 (depends on 24)

The method of claim 24, wherein the syringe cap further includes a plug portion having a first end and a second end, wherein the plug portion is configured to attach to the delivery end of the syringe.

### Claim 30 (depends on 29)

The method of claim 29, wherein the protruding member extends from the second end of the plug portion.

### Claim 31 (depends on 24)

The method of claim 24, wherein the protruding member extends about 2 mm to about 20 mm.

### Claim 32

A method of degassing a composition in a syringe, the method comprising:
removing gas from the composition, including a first component and a second component, within the syringe after removing a syringe cap including a protruding member that extends a length greater than a depth of the second component when accumulated.

### Claim 33 (depends on 32)

The method of claim 32, wherein the protruding member is configured to create a tunnel through the second component when accumulated.

### Claim 34 (depends on 33)

The method of claim 33, wherein the protruding member extends longitudinally into the syringe to create the tunnel through the second component when accumulated.

### Claim 35 (depends on 34)

The method of claim 34, wherein the protruding member extends about 2 mm to about 20 mm.

### Claim 36 (depends on 32)

The method of claim 32, wherein the syringe cap further includes a plug portion having a first end and a second end, wherein the plug portion is configured to attach to the delivery end of the syringe.

### Claim 37 (depends on 36)

The method of claim 36, wherein the protruding member extends from the second end of the plug portion.
